Show simple item record

dc.creatorHook, Magnus A.
dc.creatorBrown, Eric L.
dc.date.accessioned2019-06-17T16:57:27Z
dc.date.available2019-06-17T16:57:27Z
dc.date.issued2003-02-11
dc.identifier.urihttps://hdl.handle.net/1969.1/176724
dc.description.abstractBorrelia burgdorferi, the causative agent of Lyme disease, expresses on its surface a decorin binding protein, DbpA and DbpB. Lysine residues necessary for DbpA binding to decorin and DbpA peptides containing these critical residues essential for decorin binding are disclosed. It is further disclosed that vaccination using peptides incorporating these critical binding domains of DbpA can confer a delayed-type hypersensitivity response to DbpA and reduce the number of B. burgdorferi organisms present in infected animals.en
dc.languageeng
dc.publisherUnited States. Patent and Trademark Office
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titleDecorin binding protein essential peptides and methods of useen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeThe Texas A&M University System
dc.identifier.patentapplicationnumber09/596120
dc.subject.uspcprimary424/185.1
dc.subject.uspcother424/130.1
dc.subject.uspcother424/184.1
dc.subject.uspcother424/234.1
dc.subject.uspcother435/7.2
dc.subject.uspcother530/324
dc.date.filed2000-06-16
dc.publisher.digitalTexas A&M University. Libraries
dc.subject.cpcprimaryC07K 14/20
dc.subject.cpcprimaryY02A 50/30
dc.subject.cpcprimaryY02A 50/401
dc.subject.cpcprimaryA61K 39/00


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record